DEFINITIVE INFORMATION STATEMENT ON SCHEDULE 14C

Company

IOVANCE BIOTHERAPEUTICS, INC.

Filed

August 20, 2013

Period of Report

August 22, 2013

Accession Number

0001513160-13-000050